Ciclesonide



Indications and Reactions:

Role Indications Reactions
Primary
Rhinitis Perennial 73.3%
Rhinitis Allergic 13.3%
Asthma 6.7%
Product Used For Unknown Indication 6.7%
Chest Pain 23.5%
Herpes Zoster 11.8%
Atrial Septal Defect Acquired 5.9%
Confusional State 5.9%
Drug Screen Positive 5.9%
Endometrial Hyperplasia 5.9%
Epistaxis 5.9%
Exposure During Pregnancy 5.9%
Pruritus 5.9%
Suffocation Feeling 5.9%
Upper Respiratory Tract Congestion 5.9%
Uterine Polyp 5.9%
Ventricular Septal Defect 5.9%
Secondary
Asthma 46.7%
Chronic Obstructive Pulmonary Disease 13.3%
Multiple Allergies 6.7%
Product Used For Unknown Indication 6.7%
Anxiety 4.4%
Bronchiolitis 4.4%
Fibromyalgia 4.4%
Wheezing 4.4%
Drug Use For Unknown Indication 2.2%
Hypertension 2.2%
Pharyngitis 2.2%
Sinusitis 2.2%
Wheezing 21.4%
Drug Ineffective 14.3%
Myalgia 14.3%
Foetal Death 7.1%
Increased Upper Airway Secretion 7.1%
Nasal Congestion 7.1%
Oral Candidiasis 7.1%
Pulmonary Function Test Decreased 7.1%
Somnolence 7.1%
Urosepsis 7.1%
Concomitant
Asthma 21.7%
Prophylaxis 16.8%
Product Used For Unknown Indication 14.9%
Hypertension 5.4%
Drug Use For Unknown Indication 4.7%
Essential Hypertension 3.9%
Insomnia 3.2%
Chronic Obstructive Pulmonary Disease 3.0%
Contraception 3.0%
Osteoporosis 3.0%
Rheumatoid Arthritis 3.0%
Pain 2.8%
Constipation 2.3%
Diarrhoea 2.1%
Thyroid Cancer 1.9%
Cataplexy 1.8%
Gastrooesophageal Reflux Disease 1.8%
Premenstrual Syndrome 1.8%
Depression 1.6%
Gastric Disorder 1.6%
Weight Increased 12.7%
Acute Myocardial Infarction 6.3%
Fatigue 6.3%
Pneumonia 6.3%
Rash Erythematous 6.3%
Cardiac Failure 4.8%
Drug Interaction 4.8%
International Normalised Ratio Increased 4.8%
Lung Disorder 4.8%
Nervousness 4.8%
Pneumothorax 4.8%
Pulmonary Embolism 4.8%
Weight Decreased 4.8%
Wheezing 4.8%
Balance Disorder 3.2%
Blood Bilirubin Increased 3.2%
Blood Glucose Increased 3.2%
Blood Pressure Increased 3.2%
Breast Cancer 3.2%
Cognitive Disorder 3.2%